Ginkgo Bioworks Holdings (DNA) Accumulated Depreciation & Amortization (2020 - 2025)

Ginkgo Bioworks Holdings filings provide 6 years of Accumulated Depreciation & Amortization readings, the most recent being $190.6 million for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 18.48% to $190.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $190.6 million, a 18.48% increase, with the full-year FY2025 number at $190.6 million, up 18.48% from a year prior.
  • Accumulated Depreciation & Amortization hit $190.6 million in Q4 2025 for Ginkgo Bioworks Holdings, up from $182.1 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $190.6 million in Q4 2025 to a low of $53.8 million in Q3 2021.
  • Median Accumulated Depreciation & Amortization over the past 5 years was $120.7 million (2023), compared with a mean of $121.9 million.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: soared 80.74% in 2021 and later increased 14.99% in 2024.
  • Ginkgo Bioworks Holdings' Accumulated Depreciation & Amortization stood at $61.1 million in 2021, then surged by 51.93% to $92.8 million in 2022, then soared by 30.15% to $120.7 million in 2023, then skyrocketed by 33.26% to $160.9 million in 2024, then rose by 18.48% to $190.6 million in 2025.
  • The last three reported values for Accumulated Depreciation & Amortization were $190.6 million (Q4 2025), $182.1 million (Q3 2025), and $173.5 million (Q2 2025) per Business Quant data.